The potential interaction between clopidogrel and proton pump inhibitors: a systematic review

[1] Yusuf S(2001)Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 494-502

[2] Zhao F(1992)Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel Biochem Pharmacol 44 527-532

[3] Mehta SR(2010)Genotyping, clopidogrel metabolism, and the search for the therapeutic window of thienopyridines Circulation 121 481-483

[4] Chrolavicius S(2003)Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction Circulation 107 32-37

[5] Tognoni G(2003)Atorvastatin-clopidogrel interaction Circulation 107 e223-1338

[6] Fox KK(2004)Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes Circulation 109 1335-1153

[7] Savi P(2009)Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study J Am Coll Cardiol 54 1149-260

[8] Herbert JM(2008)Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study J Am Coll Cardiol 51 256-484

[9] Pflieger AM(2009)Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel Am Heart J 157 148-944

[10] Dol F(2008)Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel J Clin Pharmacol 48 475-718

[1] Yusuf S(2001)Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 494-502

[2] Zhao F(1992)Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel Biochem Pharmacol 44 527-532

[3] Mehta SR(2010)Genotyping, clopidogrel metabolism, and the search for the therapeutic window of thienopyridines Circulation 121 481-483

[4] Chrolavicius S(2003)Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction Circulation 107 32-37

[5] Tognoni G(2003)Atorvastatin-clopidogrel interaction Circulation 107 e223-1338

[6] Fox KK(2004)Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes Circulation 109 1335-1153

[7] Savi P(2009)Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study J Am Coll Cardiol 54 1149-260

[8] Herbert JM(2008)Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study J Am Coll Cardiol 51 256-484

[9] Pflieger AM(2009)Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel Am Heart J 157 148-944

[10] Dol F(2008)Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel J Clin Pharmacol 48 475-718